In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...

In this randomized controlled trial, among patients with atrial fibrillation requiring anticoagulation therapy, asundexian ...